Sökning: WFRF:(Lammertsma Adriaan A.) >
[11C]Flumazenil bra...
-
Froklage, Femke E
(författare)
[11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoprotein.
- Artikel/kapitelEngelska2012
Förlag, utgivningsår, omfång ...
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-185288
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-185288URI
-
https://doi.org/10.1186/2191-219X-2-12DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
BACKGROUND: [11C]Flumazenil and positron emission tomography (PET) are used clinically to assess gamma-aminobutyric acid (GABA)-ergic function and to localize epileptic foci prior to resective surgery. Enhanced P-glycoprotein (P-gp) activity has been reported in epilepsy and this may confound interpretation of clinical scans if [11C]flumazenil is a P-gp substrate. The purpose of this study was to investigate whether [11C]flumazenil is a P-gp substrate.METHODS: [11C]Flumazenil PET scans were performed in wild type (WT) (n = 9) and Mdr1a/1b, (the genes that encode for P-gp) double knockout (dKO) (n = 10) mice, and in naive rats (n = 10). In parallel to PET scanning, [11C]flumazenil plasma concentrations were measured in rats. For 6 of the WT and 6 of the dKO mice a second, [11C]flumazenil scan was acquired after administration of the P-gp inhibitor tariquidar. Cerebral [11C]flumazenil concentrations in WT and Mdr1a/1b dKO mice were compared (genetic disruption model). Furthermore, pre and post P-gp-blocking cerebral [11C]flumazenil concentrations were compared in all animals (pharmacological inhibition model).RESULTS: Mdr1a/1b dKO mice had approximately 70% higher [11C]flumazenil uptake in the brain than WT mice. After administration of tariquidar, cerebral [11C]flumazenil uptake in WT mice increased by about 80% in WT mice, while it remained the same in Mdr1a/1b dKO mice. In rats, cerebral [11C]flumazenil uptake increased by about 60% after tariquidar administration. Tariquidar had only a small effect on plasma clearance of flumazenil.CONCLUSIONS: The present study showed that [11C]flumazenil is a P-gp substrate in rodents. Consequently, altered cerebral [11C]flumazenil uptake, as observed in epilepsy, may not reflect solely GABAA receptor density changes but also changes in P-gp activity.
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Syvänen, StinaLeiden University(Swepub:uu)stsyv838
(författare)
-
Hendrikse, N Harry
(författare)
-
Huisman, Marc C
(författare)
-
Molthoff, Carla Fm
(författare)
-
Tagawa, Yoshihiko
(författare)
-
Reijneveld, Jaap C
(författare)
-
Heimans, Jan J
(författare)
-
Lammertsma, Adriaan A
(författare)
-
Eriksson, JonasVU University Medical Center Amsterdam(Swepub:uu)joeri542
(författare)
-
de Lange, Elizabeth Cm
(författare)
-
Voskuyl, Rob A
(författare)
-
Leiden UniversityVU University Medical Center Amsterdam
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:EJNMMI Research2, s. 12-2191-219X
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Froklage, Femke ...
-
Syvänen, Stina
-
Hendrikse, N Har ...
-
Huisman, Marc C
-
Molthoff, Carla ...
-
Tagawa, Yoshihik ...
-
visa fler...
-
Reijneveld, Jaap ...
-
Heimans, Jan J
-
Lammertsma, Adri ...
-
Eriksson, Jonas
-
de Lange, Elizab ...
-
Voskuyl, Rob A
-
visa färre...
- Artiklar i publikationen
-
EJNMMI Research
- Av lärosätet
-
Uppsala universitet